newsfilter
← Latest News
Business Wire·

enGene Achieves Target Enrollment Milestone for LEGEND Trial Pivotal Cohort

Target enrollment of 100 patients with high-risk, BCG-unresponsive NMIBC with CIS achieved enGene plans to provide an update from LEGEND's pivotal cohort in 4Q 2025 Biologic License Application (BLA) submission